Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

1.03
-0.0400-3.76%
Post-market: 1.040.0145+1.41%19:59 EDT
Volume:22.25M
Turnover:23.23M
Market Cap:346.98M
PE:-4.02
High:1.10
Open:1.10
Low:1.01
Close:1.07
52wk High:2.73
52wk Low:1.01
Shares:338.52M
Float Shares:327.56M
Volume Ratio:2.13
T/O Rate:6.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2551
EPS(LYR):-0.2260
ROE:-660.00%
ROA:-48.44%
PB:-20.96
PE(LYR):-4.53

Loading ...

Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 29

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Apr 28

Ocugen CEO to present at Oppenheimer Innovation on the Island Biotech Summit

Reuters
·
Apr 23

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 23

A Look At Ocugen (OCGN) Valuation After Positive OCU410 Phase 2 ArMaDa Trial Results

Simply Wall St.
·
Apr 22

Ocugen Inc. Stock Sheds 4.3%, Underperforms Market

Dow Jones
·
Apr 22

What Ocugen (OCGN)'s Strong OCU410 Phase 2 GA Data Means For Shareholders

Simply Wall St.
·
Apr 21

Ocugen Inc. Stock Slides 7.0%, Underperforms Market

Dow Jones
·
Apr 21

Ocugen announces annual shareholder meeting webcast

Reuters
·
Apr 18

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Apr 17

Ocugen Inc. Stock Rallies 8.3%, Outperforms Market

Dow Jones
·
Apr 16

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Apr 14

Ocugen Inc. Stock Falls 5.9%, Underperforms Market

Dow Jones
·
Apr 11

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Apr 08

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 07

Ocugen (OCGN) Receives a Buy from Noble Financial

TIPRANKS
·
Apr 06

Assessing Ocugen (OCGN) Valuation After Strong One Year Share Price Momentum

Simply Wall St.
·
Apr 04

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences

Reuters
·
Apr 02

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

MT Newswires Live
·
Apr 01

Ocugen completes dosing in GARDian3 trial

TIPRANKS
·
Apr 01